A Study of Neurophysiological and Inflammatory Biomarkers of Seizures and Brain Injury in Children


  • Study type

  • Study IDs

  • Describes the nature of a clinical study. Types include:

    • Observational study — observes people and measures outcomes without affecting results.
    • Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
    • Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
  • Site IRB
    • Rochester, Minnesota: 16-005512
    Sponsor Protocol Number: 16-005512

About this study

The purpose of this study is to connect brain inflammation measured by biomarkers, with data from advanced EEG technology, and clinical outcomes to provide new predictive information about seizure activity in children with critical brain injuries and epilepsy.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

See eligibility criteria

Inclusion Criteria

  • Neonates with moderate to severe hypoxic ischemic encephalopathy admitted to the Mayo Clinic neonatal ICU
  • Children with altered mental status admitted to Mayo Clinic pediatric ICU
  • Children (1 month to 18 years) with an epileptic encephalopathy, refractory epilepsy and multiple daily seizures, admitted to our pediatric epilepsy monitoring unit (PEMU) for seizure frequency classification
  • Children (1 month to 18 years) without epilepsy admitted to our PEMU for spell classification and who do not have seizures  

Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Eric Payne, M.D.

Open for enrollment

Contact information:

Eric Payne M.D.